109 related articles for article (PubMed ID: 20661130)
1. Expression of the retinoblastoma-related gene Rb2/p130 in the pathogenesis of serous carcinoma of the ovary.
Worley MJ; Landen CN; Slomovitz BM; Malpica A; Palla SL; Ramirez PT
Appl Immunohistochem Mol Morphol; 2010 Dec; 18(6):509-11. PubMed ID: 20661130
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic application of lectin histochemistry: bisecting GlcNAc in glioblastoma.
Aoyanagi E; Sasai K; Nodagashira M; Wang L; Nishihara H; Ihara H; Ikeda Y; Tanaka S
Appl Immunohistochem Mol Morphol; 2010 Dec; 18(6):518-25. PubMed ID: 20661133
[TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis of follicle-stimulating hormone receptor in ovarian epithelial tumors: a novel approach to explain the field effect of ovarian cancer development in secondary mullerian systems.
Wang J; Lin L; Parkash V; Schwartz PE; Lauchlan SC; Zheng W
Int J Cancer; 2003 Jan; 103(3):328-34. PubMed ID: 12471615
[TBL] [Abstract][Full Text] [Related]
4. Decreased luteinizing hormone receptor mRNA expression in human ovarian epithelial cancer.
Lu JJ; Zheng Y; Kang X; Yuan JM; Lauchlan SC; Pike MC; Zheng W
Gynecol Oncol; 2000 Nov; 79(2):158-68. PubMed ID: 11063638
[TBL] [Abstract][Full Text] [Related]
5. p63 expression in epithelial ovarian tumors.
Poli Neto OB; Candido Dos Reis FJ; Zambelli Ramalho LN; Nogueira AA; de Andrade JM
Int J Gynecol Cancer; 2006; 16(1):152-5. PubMed ID: 16445626
[TBL] [Abstract][Full Text] [Related]
6. Nuclear survivin is associated with malignant potential in epithelial ovarian carcinoma.
Qian X; Xi X; Li L
Appl Immunohistochem Mol Morphol; 2011 Mar; 19(2):126-32. PubMed ID: 20724919
[TBL] [Abstract][Full Text] [Related]
7. Expression of glucose transporter protein 1 and p63 in serous ovarian tumor.
Cai Y; Zhai JJ; Feng BB; Duan XZ; He XJ
J Obstet Gynaecol Res; 2014 Jul; 40(7):1925-30. PubMed ID: 25056472
[TBL] [Abstract][Full Text] [Related]
8. Fascin expression in serous tumors of ovary correlates with aggressiveness of malignancy.
Wen YH; Yee H; Goswami S; Shukla PS
Int J Gynecol Pathol; 2009 Mar; 28(2):187-92. PubMed ID: 19188814
[TBL] [Abstract][Full Text] [Related]
9. Expression of extracellular matrix proteins in ovarian serous tumors.
Salani R; Neuberger I; Kurman RJ; Bristow RE; Chang HW; Wang TL; Shih IeM
Int J Gynecol Pathol; 2007 Apr; 26(2):141-6. PubMed ID: 17413980
[TBL] [Abstract][Full Text] [Related]
10. [Expression and significance of GLUT-1 and DNA-PKcs in serous ovarian tumors].
Cai Y; Shao SL; Wang QH; Yan LJ; Wang XY; Wang LX
Ai Zheng; 2007 Nov; 26(11):1188-93. PubMed ID: 17991316
[TBL] [Abstract][Full Text] [Related]
11. Frequent loss of pRb2/p130 in human ovarian carcinoma.
D'Andrilli G; Masciullo V; Bagella L; Tonini T; Minimo C; Zannoni GF; Giuntoli RL; Carlson JA; Soprano DR; Soprano KJ; Scambia G; Giordano A
Clin Cancer Res; 2004 May; 10(9):3098-103. PubMed ID: 15131049
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the clinical behavior of newly diagnosed stages II-IV low-grade serous carcinoma of the ovary with that of serous ovarian tumors of low malignant potential that recur as low-grade serous carcinoma.
Shvartsman HS; Sun CC; Bodurka DC; Mahajan V; Crispens M; Lu KH; Deavers MT; Malpica A; Silva EG; Gershenson DM
Gynecol Oncol; 2007 Jun; 105(3):625-9. PubMed ID: 17320156
[TBL] [Abstract][Full Text] [Related]
13. Progressive loss of selenium-binding protein 1 expression correlates with increasing epithelial proliferation and papillary complexity in ovarian serous borderline tumor and low-grade serous carcinoma.
Zhang C; Wang YE; Zhang P; Liu F; Sung CJ; Steinhoff MM; Quddus MR; Lawrence WD
Hum Pathol; 2010 Feb; 41(2):255-61. PubMed ID: 19896693
[TBL] [Abstract][Full Text] [Related]
14. Low malignant potential tumors with micropapillary features are molecularly similar to low-grade serous carcinoma of the ovary.
May T; Virtanen C; Sharma M; Milea A; Begley H; Rosen B; Murphy KJ; Brown TJ; Shaw PA
Gynecol Oncol; 2010 Apr; 117(1):9-17. PubMed ID: 20117829
[TBL] [Abstract][Full Text] [Related]
15. Lectin binding to serous ovarian tumours.
Söderström KO
J Clin Pathol; 1988 Mar; 41(3):308-13. PubMed ID: 2452177
[TBL] [Abstract][Full Text] [Related]
16. Mutations in the retinoblastoma-related gene RB2/p130 in lung tumors and suppression of tumor growth in vivo by retrovirus-mediated gene transfer.
Claudio PP; Howard CM; Pacilio C; Cinti C; Romano G; Minimo C; Maraldi NM; Minna JD; Gelbert L; Leoncini L; Tosi GM; Hicheli P; Caputi M; Giordano GG; Giordano A
Cancer Res; 2000 Jan; 60(2):372-82. PubMed ID: 10667590
[TBL] [Abstract][Full Text] [Related]
17. Characterization of alterations of Rb2/p130 tumor suppressor in all-trans-retinoic acid resistant SK-OV3 ovarian carcinoma cells.
Fields AL; Soprano DR; Soprano KJ
J Cell Physiol; 2008 Oct; 217(1):77-85. PubMed ID: 18446820
[TBL] [Abstract][Full Text] [Related]
18. Reduction of BRCA1 expression in sporadic ovarian cancer.
Zheng W; Luo F; Lu JJ; Baltayan A; Press MF; Zhang ZF; Pike MC
Gynecol Oncol; 2000 Mar; 76(3):294-300. PubMed ID: 10684699
[TBL] [Abstract][Full Text] [Related]
19. [Expression of topoisomerase III alpha in epithelial ovarian tumors of different types and relation between the expression of topoisomerase III alpha and the clinical pathology of tumor].
Zhang WY; Pan Y; Zhu LR; Zhang JZ; Zhang M; Feng K; Zhou L; Yu L; Zhang XM; Ng SW
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(42):2988-91. PubMed ID: 16324386
[TBL] [Abstract][Full Text] [Related]
20. Role of Retinoblastoma Protein Family (Rb/p105 and Rb2/p130) Expression in the Histopathological Classification of Borderline Ovarian Tumors.
Masciullo V; Valdivieso P; Amadio G; Santoro A; Angelico G; Sgambato A; Boffo S; Giordano A; Scambia G; Zannoni GF
Front Med (Lausanne); 2020; 7():596226. PubMed ID: 33262995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]